Lv1
40 积分 2024-12-17 加入
Clinical markers predict the efficacy of several immune checkpoint inhibitors in patients with non-small cell lung cancer in China
6个月前
已完结
Decreased monocyte-to-lymphocyte ratio was associated with satisfied outcomes of first-line PD-1 inhibitors plus chemotherapy in stage IIIB-IV non-small cell lung cancer
6个月前
已完结
The clinical outcomes of combined stereotactic radiosurgery with PD-1/PD-L1 inhibitors in patients with metastatic brain tumors: a systematic review and meta-analysis on the safety and efficacy
10个月前
已完结
Nivolumab plus ipilimumab with chemotherapy for non–small cell lung cancer with untreated brain metastases: a multicenter single-arm phase 2 trial (NIke, LOGiK 2004)
1年前
已完结
Immune Checkpoint Inhibitors as First-line Treatment for Brain Metastases in Stage IV NSCLC Patients without Driver Mutations
1年前
已完结
皖公网安备34019202002308
